International Clinical Trial: Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315841) titled 'Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery' on Dec. 19, 2025.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Condition: Tenosynovial Giant Cell Tumor

Intervention: Drug: Indocyanine Green

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: January 2026

Target Sample Size: 40

To know more, visit https://clinicaltrials.gov/study/NCT073...